Metabolic effects of antihypertensive treatment with beta-blockers.
The beneficial effects of beta-blockers on morbidity and mortality have been demonstrated in several prospective long-term trials. The suspected negative metabolic effects of low-dose beta 1-selective-blockers do not appear to be relevant to daily clinical practice, and do not restrict the use of these agents as first choice antihypertensive drugs in diabetic or non-diabetic patients.
Department of Nutrition and Metabolism, WHO Collaborating Center for Diabetes, Heinrich-Heine University, Düsseldorf, Germany.
P T
PT
Sawicki
M
M
Berger
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D003920:Diabetes Mellitus / Q000139:chemically induced*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007003:Hypoglycemia / Q000139:chemically induced*; D008055:Lipids / Q000097:blood
D000319:Adrenergic beta-Antagonists; D008055:Lipids; D005947:Glucose